Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Source: pr-inside.com
Orphan Products Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Orphan Products Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Orphan Products Development Today - Breaking & Trending Today
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Source: prnewswire.com
Baystreet.ca - Solinex Down on Orphan Drug Designation
Soligenix, Inc. (NASDAQ: SNGX) saw its stock prices slightly off early Thursday. The Princeton, New Jersey-based company, a late-stage biopharmaceutical concern focused on developing and commercializing products to treat rare diseases where there is ...
Source: baystreet.ca
BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
CAB-CTLA-4 (BA3071) Phase 1 study cleared dose-limiting toxicity (DLT) observation period with 700 mg (10 mg/kg); initial Phase 2 monotherapy data...
Source: businessinsider.com
FDA Helps to Deliver Meaningful Advances for Rare Disease Patients
We remain committed to supporting rare disease research, engaging patients and caregivers to understand their unique perspectives, and enhancing our review processes to advance medical products for rare disease patients.
Source: fda.gov